• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Redesigning and Revaluing HSA Plans

Article

Amid two seemingly unrelated trends, the rise of high-deductible health plans and the growing prevalence and burden of chronic diseases, it may time to rethink the concept and regulation of preventive services, argue advocates of value-based insurance.

Amid two seemingly unrelated trends, the rise of high-deductible health plans and the growing prevalence and burden of chronic diseases, it may time to rethink the concept and regulation of preventive services, argue advocates of value-based insurance.

Any of the 18 million Americans diagnosed with diabetes and enrolled in a high-deductible health plan with a health savings account has to pay for glucose, blood pressure, cholesterol and eye tests, among other necessities, out-of-pocket before hitting their deductible, as dictated by Internal Revenue Service regulations for HSA-eligible plans.

Depending on a person’s income, that can be a disincentive to get a test or take a medication in the short-run, but in the long-run potentially lead to avoidable complications and unnecessary spending.

Read the full story here: http://bit.ly/1guYmN1

Source: Healthcare Payer News

Related Videos
Diana Isaacs, PharmD
Beau Raymond, MD
Robert Zimmerman, MD
Beau Raymond, MD
Dr Kevin Mallow, PharmD, BCPS, BC-ADM, CDCES
Ian Neeland, MD
Chase D. Hendrickson, MD, MPH
Steven Coca, MD, MS, Icahn School of Medicine, Mount Sinai
Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine.
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.